Search
Viridian Therapeutics Inc
VRDNAdd to Watchlist
18.250USD
-0.230-1.25%
Close 07/01, 16:00（ET）Quotes delayed by 15 min
1.87BMarket Cap
LossP/E TTM
Viridian Therapeutics Inc Earnings Date
Period
FY2025 Earnings Date
Revenue(YoY)
70.85M
23359.93%
EPS(YoY)
-4.04
-1.60%
Analyst Rating
BUY
2026-07-01
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What is the total revenue of Viridian Therapeutics Inc?
According to Viridian Therapeutics Inc's FY2025 earnings report, its total revenue reached 70.85M, with a year-on-year change of 23359.93.
What are the current assets of Viridian Therapeutics Inc?
According to Viridian Therapeutics Inc's FY2025 earnings report, its current assets were 894.23M, with a year-on-year change of 21.09.
What are the total assets of Viridian Therapeutics Inc?
According to Viridian Therapeutics Inc's FY2025 earnings report, its total assets of Viridian Therapeutics Inc were 899.42M, with a year-on-year change of 21.15.
What are the total liabilities of Viridian Therapeutics Inc?
According to Viridian Therapeutics Inc's FY2025 earnings report, its total liabilities of Viridian Therapeutics Inc were 177.25M, with a year-on-year change of 150.48.
What is the total equity of Viridian Therapeutics Inc?
According to Viridian Therapeutics Inc's FY2025 earnings report, its total equity of Viridian Therapeutics Inc was 722.17M, with a year-on-year change of 7.52.
What is the net investment of Viridian Therapeutics Inc?
According to Viridian Therapeutics Inc's FY2025 earnings report, its net investment of Viridian Therapeutics Inc was -37.56M, with a year-on-year change of 83.57.
What is the net financing of Viridian Therapeutics Inc?
According to Viridian Therapeutics Inc's FY2025 earnings report, its net financing of Viridian Therapeutics Inc was 426.74M, with a year-on-year change of -6.77.
What is the Earnings Per Share (EPS) of Viridian Therapeutics Inc?
According to Viridian Therapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -4.04, with a year-on-year change of -1.60.
What is the net margin of Viridian Therapeutics Inc?
According to Viridian Therapeutics Inc's FY2025 earnings report, its net profit margin was -483.57, with a year-on-year change of 99.46.
What is the debt-to-asset ratio of Viridian Therapeutics Inc?
According to Viridian Therapeutics Inc's FY2025 earnings report, its debt-to-asset ratio was 9.36, with a year-on-year change of 237.61.
What is the Return on Equity (ROE) of Viridian Therapeutics Inc?
According to Viridian Therapeutics Inc's FY2025 earnings report, its Return on Equity (ROE) was -63.87, with a year-on-year change of 15.03.
What is the Return on Assets (ROA) of Viridian Therapeutics Inc?
According to Viridian Therapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was -41.73, with a year-on-year change of 4.70.
What is the operating profit of Viridian Therapeutics Inc?
According to Viridian Therapeutics Inc's FY2025 earnings report, its operating profit was -324.92M, with a year-on-year change of -8.66.